20/20 Biolabs, Inc. AIDX

Full chart Compare
Set alert

Price alert · AIDX

All alert types
0.19 USD -0.04 (-18.35%)

At closeNov 5, 2026, 6:01 PM EST

0.19 0.00 +0.05%

After hours · Nov 5, 6:01 PM ET

0.1806 Day range 0.2277
0.1806 52-week range 50.00
YTD
-99.22%
1 year
-99.22%

Revenue & Expenses

Revenue → Gross Profit: $604.54KGross Profit → Expenses: $604.54KRevenue → Cost of Revenue: $1.44MExpenses → Selling, General & Admin: $3.34MExpenses → Research & Development: $592.57KExpenses → Interest Expense: $156.21KExpenses → Other Expenses: $251.74KNet Loss → Expenses: $3.74MGross Profit$604.54KNet Loss$3.74MCost of Revenue$1.44MExpenses$4.34MSelling, General & Admin$3.34MResearch & Development$592.57KInterest Expense$156.21KOther Expenses$251.74KRevenue$2.05M

Latest period ending Dec 31, 2025 · select a line to chart its full history

AIDX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
2.05M1.75M1.42M
604.54K360.31K109.14K
-3.33M-5.66M-6.36M
-3.74M-5.55M-6.39M
-0.76-1.16-1.34
AIDX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
1.03M1.78M4.09M
4.14M3.58M6.37M
4.16M2.08M2.08M
1.36M839.55K1.23M
-19.23K1.51M4.29M
AIDX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
-1.92M-2.60M-4.48M
1.16M293.33K-194.38K
-758.02K-2.31M-4.72M